Cerebrospinal Fluid and Plasma Viral Load in HIV-1-infected Patients with Various Anti-retroviral Treatment Regimens

By GisslÉn Magnus   Svennerholm Bo   Norkrans Gunnar   FranzÉn Christer   SÄll Christer   Svensson Rune   Öberg Sven   Hagberg Lars  

Scandinavian Journal of Infectious Diseases, Vol. 32, Iss. 4, 2000-10 ,pp. : 365-369

Informa Healthcare

Access to resources Recommend Favorite

Treating Older HIV-1-infected Subjects With Cobicistat-boosted Darunavir in a 48-week Phase 3 Trial

By  

Reviews on Recent Clinical Trials, Vol. 12, Iss. 3, 2017-11 ,pp. : 174-181

Bentham Science Publishers

Access to resources Recommend Favorite

Cerebrospinal fluid and plasma HIV-1 RNA levels and lopinavir concentrations following lopinavir/ritonavir regimen

By Yilmaz Aylin   Ståhle Lars   Hagberg Lars   Svennerholm Bo   Fuchs Dietmar   Gisslén Magnus  

Scandinavian Journal of Infectious Diseases, Vol. 36, Iss. 11-12, 2004-12 ,pp. : 823-828

Informa Healthcare

Access to resources Recommend Favorite

Efficacy, safety, and pharmacokinetics of once-daily boosted darunavir in pretreated HIV-infected patients

By Zucman David   De Truchis P.   Peytavin Gilles   Descamps Diane   Duvivier C.   Tegna L.   Weiss Laurence   Delassus Jean L.   Benalycherif A.   Landman Roland  

Scandinavian Journal of Infectious Diseases, Vol. 45, Iss. 5, 2013-05 ,pp. : 407-410

Informa Healthcare

Access to resources Recommend Favorite

Viral Load and CD4+ Cell Count as Risk Factors for Prolonged QT Interval in HIV-Infected Subjects: A Cohort-Nested Case-Control Study in an Outpatient Population

By  

Cardiology, Vol. 117, Iss. 2, 2010-10 ,pp. : 105-111

Karger

Access to resources Recommend Favorite